Research Letter: Limited Additional Serious Adverse Events Associated with Concomitant Immunomodulatory Treatment in People with Atypical Psychiatric Disease
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Bost C, Pascual O, Honnorat J
. Autoimmune encephalitis in psychiatric institutions: current perspectives. Neuropsychiatr Dis Treat. 2016; 12:2775-2787.
PMC: 5089825.
DOI: 10.2147/NDT.S82380.
View
2.
Robichon K, Sondhauss S, Jordan T, Keyzers R, Connor B, La Flamme A
. Localisation of clozapine during experimental autoimmune encephalomyelitis and its impact on dopamine and its receptors. Sci Rep. 2021; 11(1):2966.
PMC: 7858600.
DOI: 10.1038/s41598-021-82667-6.
View
3.
Al Abadey A, Connor B, La Flamme A, Robichon K
. Clozapine reduces chemokine-mediated migration of lymphocytes by targeting NF-κB and AKT phosphorylation. Cell Signal. 2022; 99:110449.
DOI: 10.1016/j.cellsig.2022.110449.
View
4.
Jiang J, Fewings N, Dervish S, Fois A, Duma S, Silsby M
. Novel Surrogate Markers of CNS Inflammation in CSF in the Diagnosis of Autoimmune Encephalitis. Front Neurol. 2020; 10:1390.
PMC: 7034172.
DOI: 10.3389/fneur.2019.01390.
View
5.
Jeppesen R, Christensen R, Pedersen E, Nordentoft M, Hjorthoj C, Kohler-Forsberg O
. Efficacy and safety of anti-inflammatory agents in treatment of psychotic disorders - A comprehensive systematic review and meta-analysis. Brain Behav Immun. 2020; 90:364-380.
DOI: 10.1016/j.bbi.2020.08.028.
View